Scientific Digital Imaging sells to China's food and drug regulator

Scientific Digital Imaging on Friday said it sold 25 of its ProtoCOL 3 technology to the Chinese State Food and Drug Administration.

Scientific Digital Imaging on Friday said it sold 25 of its ProtoCOL 3 technology to the Chinese State Food and Drug Administration.

ProtoCOL 3 is colony counter, an instrument used to count colonies of bacteria and other microorganisms.

The government organisation paid $120,000 for the products to aid in vaccine and antibiotic testing at regional laboratories across China.

It is the largest order of colony counters this year which came via the company's distributor Hua Yue Enterprise Holdings. The firm sold 27 in Asia last year.

"Selling the ProtoCOL 3 systems to the Chinese equivalent of the [Food and Drug Administration] is a coup," Chairman of Scientific Digital Imaging, Ken Ford, said.

"Our technology was in a rigorous tender process against systems from 10 other US, European and Chinese companies so to come out on top is a boost, not just for our Synbiosis Division, but also for other life science firms in Cambridge's innovation hub."

Shares rose 2.44% to 21.00p at 11:22 Friday.

RD

Recommended

Three sustainable stocks that are doing well by doing good
Share tips

Three sustainable stocks that are doing well by doing good

Professional investor Peter Michaelis of the Liontrust Sustainable Investment Team picks three stocks to buy that are helping to create a cleaner, saf…
26 Jul 2021
Share tips of the week – 23 July
Share tips

Share tips of the week – 23 July

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
23 Jul 2021
Will Zoom’s $15bn purchase help it expand?
Tech stocks

Will Zoom’s $15bn purchase help it expand?

The videoconferencing platform became a household name during the pandemic, but it now needs new sources of growth. Alex Rankine reports
23 Jul 2021
Philip Morris goes “beyond nicotine”
Stocks and shares

Philip Morris goes “beyond nicotine”

US tobacco giant Philip Morris International has agreed to pay £1bn for British inhaler specialist Vectura.
23 Jul 2021

Most Popular

The MoneyWeek Podcast: Asia, financial repression and the nature of capitalism
Economy

The MoneyWeek Podcast: Asia, financial repression and the nature of capitalism

Russell Napier talks to Merryn about financial repression – or "stealing money from old people slowly" – plus how Asian capitalism is taking over in t…
16 Jul 2021
Why the UK's 2.5% inflation is a big deal
Inflation

Why the UK's 2.5% inflation is a big deal

After years of inflation being a financial-assets problem, it is now an “ordinary things” problem too, says Merryn Somerset Webb. But central banks st…
16 Jul 2021
An absurdly cheap healthcare stock to buy now
Share tips

An absurdly cheap healthcare stock to buy now

The pandemic has vastly accelerated the shift towards telehealth, making Cigna a long-term buy
20 Jul 2021